These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8356929)

  • 21. Midgut proteases from Mamestra configurata (Lepidoptera: Noctuidae) larvae: characterization, cDNA cloning, and expressed sequence tag analysis.
    Hegedus D; Baldwin D; O'Grady M; Braun L; Gleddie S; Sharpe A; Lydiate D; Erlandson M
    Arch Insect Biochem Physiol; 2003 May; 53(1):30-47. PubMed ID: 12701112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical biology approaches reveal conserved features of a C-terminal processing PDZ protease.
    Weski J; Meltzer M; Spaan L; Mönig T; Oeljeklaus J; Hauske P; Vouilleme L; Volkmer R; Boisguerin P; Boyd D; Huber R; Kaiser M; Ehrmann M
    Chembiochem; 2012 Feb; 13(3):402-8. PubMed ID: 22267294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional determinants of the Epstein-Barr virus protease.
    Buisson M; Valette E; Hernandez JF; Baudin F; Ebel C; Morand P; Seigneurin JM; Arlaud GJ; Ruigrok RW
    J Mol Biol; 2001 Aug; 311(1):217-28. PubMed ID: 11469870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The herpesvirus protease: mechanistic studies and discovery of inhibitors of the human cytomegalovirus protease.
    Flynn DL; Becker DP; Dilworth VM; Highkin MK; Hippenmeyer PJ; Houseman KA; Levine LM; Li M; Moormann AE; Rankin A; Toth MV; Villamil CI; Wittwer AJ; Holwerda BC
    Drug Des Discov; 1997 May; 15(1):3-15. PubMed ID: 9332827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
    Tsantrizos YS
    Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of peptidomimetic HTLV-I protease inhibitors containing hydroxymethylcarbonyl (HMC) isostere as the transition-state mimic.
    Maegawa H; Kimura T; Arii Y; Matsui Y; Kasai S; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5925-9. PubMed ID: 15501070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designed helical peptides inhibit an intramembrane protease.
    Das C; Berezovska O; Diehl TS; Genet C; Buldyrev I; Tsai JY; Hyman BT; Wolfe MS
    J Am Chem Soc; 2003 Oct; 125(39):11794-5. PubMed ID: 14505382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T
    J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and characterization of the highly thermostable proteases from Bacillus stearothermophilus TLS33.
    Sookkheo B; Sinchaikul S; Phutrakul S; Chen ST
    Protein Expr Purif; 2000 Nov; 20(2):142-51. PubMed ID: 11049738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of substrate-based inhibitors of botulinum neurotoxin type B metalloprotease.
    Oost T; Sukonpan C; Brewer M; Goodnough M; Tepp W; Johnson EA; Rich DH
    Biopolymers; 2003; 71(6):602-19. PubMed ID: 14991672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent and selective inhibition of membrane-type serine protease 1 by human single-chain antibodies.
    Sun J; Pons J; Craik CS
    Biochemistry; 2003 Feb; 42(4):892-900. PubMed ID: 12549907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significant proteases of flukes--molecular characteristic and their biological functions].
    Jarzabkowski M
    Wiad Parazytol; 2004; 50(4):657-64. PubMed ID: 16862800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the Caspase family of cysteine proteases in apoptosis.
    Miller DK
    Semin Immunol; 1997 Feb; 9(1):35-49. PubMed ID: 9106306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ser475, Glu272, Asp276, Asp327, and Asp360 are involved in catalytic activity of human tripeptidyl-peptidase I.
    Walus M; Kida E; Wisniewski KE; Golabek AA
    FEBS Lett; 2005 Feb; 579(6):1383-8. PubMed ID: 15733845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational selection of inhibitors and substrates by proteolytic enzymes: implications for drug design and polypeptide processing.
    Fairlie DP; Tyndall JD; Reid RC; Wong AK; Abbenante G; Scanlon MJ; March DR; Bergman DA; Chai CL; Burkett BA
    J Med Chem; 2000 Apr; 43(7):1271-81. PubMed ID: 10753465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [ANSA analysis. VI. Activation, inhibition and interaction of proteases in enzyme mixtures].
    Cherkasov AV; Nedospasov VA; Iakhimovich AD; Nedospasov AA
    Biokhimiia; 1994 Oct; 59(10):1574-88. PubMed ID: 7819398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteases: a primer.
    Hooper NM
    Essays Biochem; 2002; 38():1-8. PubMed ID: 12463157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia.
    Swedberg JE; de Veer SJ; Harris JM
    Biol Chem; 2010 Apr; 391(4):357-74. PubMed ID: 20180638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reaction of serine proteases with substituted 3-alkoxy-4-chloroisocoumarins and 3-alkoxy-7-amino-4-chloroisocoumarins: new reactive mechanism-based inhibitors.
    Harper JW; Powers JC
    Biochemistry; 1985 Dec; 24(25):7200-13. PubMed ID: 3910097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of active site residues of the Tsp protease.
    Keiler KC; Sauer RT
    J Biol Chem; 1995 Dec; 270(48):28864-8. PubMed ID: 7499412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.